Cognition Therapeutics Q2 EPS $(0.11), Inline
Benzinga Newsdesk 1 year ago
EarningsNews
Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 38.89 percent increase over losses of $(0.18) per share from the same period last
Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 38.89 percent increase over losses of $(0.18) per share from the same period last year.